Another novel strategy uses anti-CD47 antibodies that block the “do not eat me” CD47 and signal regulatory protein alpha (SIRPα) interactions that allow for tumor cell evasion of phagocytosis. The gene discussed is SIRPA; the disease is neoplasm.